About
David Lowe has been a research scientist managing and leading drug discovery efforts; a venture capitalist investing in emerging and mid-stage life science companies; and most recently a biotechnology entrepreneur. He started his career as a molecular biologist, joining Genentech in 1985 as a postdoctoral fellow and ultimately became a research director. David was responsible for drug discovery activities in biologics and small molecule therapeutics, efforts that resulted in eight drugs that progressed to clinical development, including two eventual products. In 2002 he joined Palo Alto, CA-based Skyline Ventures as a Kauffman Fellow. As a partner and later managing director, David led financings in start-ups to mid-stage therapeutics, diagnostics and platform technology companies. In 2012 he became co-founder and CEO of Aeglea BioTherapeutics, and Austin TX based biotechnology company developing engineered human enzymes to treat inborn errors of metabolism and cancer.
Investment Focus
- Location
- Austin, US
Contact Information
Find more investors like David
Search Investors